Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carina Strell

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Scientific Reports|November 18, 2021
TGF-β-mediated epithelial-mesenchymal transition and tumor-promoting effects in CMT64 cells are reflected in the transcriptomic signature of human lung adenocarcinomaNaoya Miyashita, Takayoshi Enokido, Masafumi Horie, et al.
Ebiomedicine|September 19, 2019
Generation of in situ sequencing based OncoMaps to spatially resolve gene expression profiles of diagnostic and prognostic markers in breast cancerJessica Svedlund, Carina Strell, Xiaoyan Qian, et al.
Breast Cancer Research and Treatment|March 4, 2021
Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trialCarina Strell, Axel Stenmark Tullberg, Reidunn Jetne Edelmann, et al.
The Journal of Pathology. Clinical Research|February 1, 2017
High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancerJanna Paulsson, Lisa Rydén, Carina Strell, et al.
Breast Cancer Research and Treatment|June 9, 2025
Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trialAxel Stenmark Tullberg, Viktoria Thurfjell, Anikó Kovács, et al.
Cellular Oncology (Dordrecht, Netherlands)|March 3, 2025
Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancerHedvig Elfving, Hui Yu, Kaleab Kassete Fessehatsion, et al.
Cancers|November 6, 2020
Prognostic Interactions between FAP+ Fibroblasts and CD8a+ T Cells in Colon CancerMercedes Herrera, Artur Mezheyeuski, Lisa Villabona, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 7, 2015
Insulin influences autophagy response distinctively in macrophages of different compartmentsKaren K S Sunahara, Fernanda P B Nunes, Marisa A P Baptista, et al.
Plos One|February 8, 2018
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancerThomas Karsten Kilvaer, Mehrdad Rakaee, Turid Hellevik, et al.
Breast Cancer Research and Treatment|May 24, 2023
Vessel size as a marker of survival in estrogen receptor positive breast cancerVladan Milosevic, Reidunn J Edelmann, Ingeborg Winge, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Scientific Reports|November 18, 2021
TGF-β-mediated epithelial-mesenchymal transition and tumor-promoting effects in CMT64 cells are reflected in the transcriptomic signature of human lung adenocarcinomaNaoya Miyashita, Takayoshi Enokido, Masafumi Horie, et al.
Ebiomedicine|September 19, 2019
Generation of in situ sequencing based OncoMaps to spatially resolve gene expression profiles of diagnostic and prognostic markers in breast cancerJessica Svedlund, Carina Strell, Xiaoyan Qian, et al.
Breast Cancer Research and Treatment|March 4, 2021
Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trialCarina Strell, Axel Stenmark Tullberg, Reidunn Jetne Edelmann, et al.
The Journal of Pathology. Clinical Research|February 1, 2017
High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancerJanna Paulsson, Lisa Rydén, Carina Strell, et al.
Breast Cancer Research and Treatment|June 9, 2025
Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trialAxel Stenmark Tullberg, Viktoria Thurfjell, Anikó Kovács, et al.
Cellular Oncology (Dordrecht, Netherlands)|March 3, 2025
Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancerHedvig Elfving, Hui Yu, Kaleab Kassete Fessehatsion, et al.
Cancers|November 6, 2020
Prognostic Interactions between FAP+ Fibroblasts and CD8a+ T Cells in Colon CancerMercedes Herrera, Artur Mezheyeuski, Lisa Villabona, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 7, 2015
Insulin influences autophagy response distinctively in macrophages of different compartmentsKaren K S Sunahara, Fernanda P B Nunes, Marisa A P Baptista, et al.
Plos One|February 8, 2018
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancerThomas Karsten Kilvaer, Mehrdad Rakaee, Turid Hellevik, et al.
Breast Cancer Research and Treatment|May 24, 2023
Vessel size as a marker of survival in estrogen receptor positive breast cancerVladan Milosevic, Reidunn J Edelmann, Ingeborg Winge, et al.
Pageof 7